Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gemcitabine (gemzar) (1 trial)
vismodegib (erivedge) (1 trial)
Carcinoma (Phase 2)
Carcinoma, Basal Cell (Phase 2)
Pancreatic Neoplasms (Phase 3)
Trials (2 total)
Trial APIs (2 total)